THE EFFECTIVENESS OF NEUROPROTECTIVE THERAPY IN ISCHEMIC STROKE
Article Sidebar
Main Article Content
Abstract
54 patients have been examined with ischemic stroke in the early recovery period. They have gone through clinic-instrumental and neuropsychologic examination. In comprasion with cerebrolysin at the dose of 10,0 ml and 30,0 ml, 30 ml dose of cerebrolisyn effected positively to intellectual-amnestic disorders, by developing its neuroprotective action. In addition, at this dose of medicine, brain bioelectrical activity has been improved faster in EEG.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Gorelick PB. The global burden of stroke: persistent and disabling // The Lancet Neurology. 2019;18(5):417–8.)
2.Jokinen H, Melkas S, Ylikoski R, et al. Poststroke cognitive impairment is common even after successful clinical recovery // Eur J Neurol. 2015 Sep; 22(9):1288-94. doi: 10.1111/ene.12743.Epub 2015 Jun 4
3.Jacquin A, Binquet C, Rouaud O, et al. Poststroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke// J Alzheimers Dis. 2014;40(4):1029-38. doi: 10.3233/JAD-131580
4.Kazakov B.Sh. Morphofunctional factors leading to individual formation of
Covid-19-associated ischemic stroke// New day in medicine - 5 (37) 2021. P. 122-124
5.Kazakov B. Sh., Khodjiyeva D. T. Clinical and Neurological Factors in the Formation of Individual Predisposition to Covid-Associated Ischemic Stroke// American Journal of Medicine and Medical Sciences 2021, 11(2): 130-133 DOI: 10.5923/j.ajmms.20211102.13
6.Khodjieva D.T., Khaydarova D.K. Clinical and neurophysiological characteristics of post-insular cognitive disorders and issues of therapy optimization // Central Asian Journal of Pediatrics. Dec. – 2019. – P. 82-86.
7.Khodjieva D.T. Review clinical assessment of the manifestations of social disadaptation in patients with cerebral stroke // Journal of Critical Reviews. 2020. – Р. 203-204.